Research Projects

Our research interests lie within three main areas : Cardiovascular Informatics, Epidemiology and Global health.   

Our current projects are:

 STIMULATE-ICP: Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways (Funded by NIHR)

Professor Banerjee leads this major consortium of over 50 researchers, health professionals, patients and industry partners from over 30 organisations, which includes the largest clinical study of long COVID to-date. See the study website for more information: https://stimulate-icp.org/

The RAPHAEL Consortium: IntegRAting a Palliative Care ApproacH for PAtients with HEart FaiLure (Funded by the EU/UKRI)

We are partners in RAPHAEL, an international, multicentre research project with a patient advisory panel at its core, alongside experts in palliative care, cardiology, and primary care. Funded by EU and UKRI. RAPHAEL’s ambition is to integrate a routine palliative care approach into heart failure care pathways across Europe through homebased multidimensional symptom monitoring. See the study website for further detail: https://palliativeprojects.eu/raphael/


This three year project aims to develop policies to address inequalities in the effective use of digital health interventions for cardiovascular disease and diabetes mellitus in ethnic minorities, particularly focusing on South Asians as a case study. See our study website: https://www.doctorasdatascientist.org/the-disc-study 

AstraZeneca: Real world evidence in asthma and chronic obstructive pulmonary disease to understand the burden of COVID-19 infection in England

A 12 month project addressing the direct and indirect effects and healthcare utilisation in individuals with chronic respiratory diseases during the COVID-19 pandemic.

World Heart Federation’s (WHF) Emerging Leaders (EL) Programme

Since 2018, Ami Banerjee has been Senior Advisor and chair to the World Heart Federation’s (WHF) Emerging Leaders (EL) Programme, which is training the next cadre of international cardiovascular researchers to achieve the WHO’s goal of reducing premature global cardiovascular mortality by 25% by 2025 (the “25 by 25” initiative). 

CaReMe UK Study (AstraZeneca)

The commonalities between cardiovascular, renal and metabolic (CaReMe) diseases are increasingly recognized, both in disease mechanisms and clinical syndromes. The overlap between CaReMe diseases results in high mortality and morbidity burden as well as challenges to a health system that largely addresses each comorbidity in isolation. Large-scale electronic health records and adv ances in data analytics offer opportunities to studying these diseases together at population level. The overall aim, in collaboration with Astra-Zeneca, is to support the identification of potential gaps in diagnostic and treatment pathways in at-risk patient groups with diabetes mellitus, heart failure and chronic kidney disease. 

European Union Erasmus scheme (PI: Prof Folkert Asselbergs, UMC Utrecht)

In this grant across 3 European countries and 10 co-investigators, Ami Banerjee is a work package and UK lead in this project (with 3 staff) where we are specifically developing online modules in international health data linkage and collaboration.